Logo image
Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamide
Journal article   Peer reviewed

Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamide

P.L. Tong, W.A. Walker, R.J. Glancy, J.P. Cooney and K. Gebauer
The Australasian Journal of Dermatology, Vol.54(1), pp.e12-e15
02/2013
url
Link to Published Version *Subscription may be requiredView

Abstract

amyloid chemotherapy CREST cyclophosphamide nodular amyloidosis primary localized cutaneous amyloidosis Sjogren's syndrome treatment
Primary localized cutaneous nodular amyloidosis (PLCNA) is a rare subtype of localized cutaneous amyloidosis and can be associated with various connective tissue disorders. It can be difficult to treat and past therapies include surgical excision, dermabrasion, electrodessication and curettage, cryotherapy and laser therapy. We present a case of a middle-aged woman with PLCNA associated with CREST (calcinosis, Raynaud phenomenon, oesophageal motility disorders, sclerodactyly and telangiectasia) syndrome and Sjögren's syndrome responding to cyclophosphamide with no new amyloid deposits and resolution of skin ulceration after many years of resistance to drug therapy. It is important to monitor these patients for progression into systemic amyloidosis.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.281 Auto-inflammatory Diseases
1.281.1236 Amyloidosis
Web Of Science research areas
Dermatology
ESI research areas
Clinical Medicine
Logo image